Be the Voice in CF Research

Ella Balasa
Person with CF

Wait – CFTR isn’t Just in the Lungs?!?

Drucy Borowitz
Senior Vice President of Community Partnerships, Cystic Fibrosis Foundation

Be the Voice in CF Research

Jp Clancy
Senior Vice President of Clinical Research, Cystic Fibrosis Foundation

After Trikafta: The Future of Modulators and Potential Effects on Treating CF

Patrick Flume
Professor of Medicine and Pediatrics

The Three R’s of CFTR: Restore, Repair, Replace
CF 101: Decoding CFTR Genetics to Transform Treatment
Closing

James Lawlor
Adult with CF

Sexual and Reproductive Health in the Era of CFTR Modulators

Megan Lepore
Adult with CF

Therapeutic Approaches for Rare and Nonsense Mutations

Xan Nowakowski
Person with CF

Sexual and Reproductive Health in the Era of CFTR Modulators

Jennifer Taylor-Cousar, MD, MSCS, ATSF
Tenured Professor of Medicine and Pediatrics, National Jewish Health

Changing CF Care in the Era of Trikafta: Are We There Yet?

Dave Nichols
Professor of Pediatrics, Seattle Children’s Hospital at the University of Washington

After Trikafta: The Future of Modulators and Potential Effects on Treating CF

George Retsch-Bogart, MD
Professor of Pediatrics

Therapeutic Approaches for Rare and Nonsense Mutations

Peter Haggie, PhD
Associate Professor, Medicine at the University of California, San Francisco

CF 101: Decoding CFTR Genetics to Transform Treatment

Elinor Langfelder-Schwind
Genetic Counselor, Regulatory Research Coordinator at Beth Israel Medical Center